Cost-Effectiveness of Exercise Therapy in Patients with Intermittent Claudication-A Comparison of Supervised Exercise, Home-Based Structured Exercise, and Walk Advice from the SUNFIT Trial

Overview

Journal J Clin Med

Specialty General Medicine

Date 2023 Aug 26

PMID 37629318

Authors

Hildigunnur Ulfsdottir

Maria Back

Asa Cider

Lennart Jivegard

Anna Sandberg

Joakim Nordanstig

Mikael Svensson

Affiliations

Soon will be listed here.

Abstract

Hospital-based supervised exercise (SEP) is a guideline-recommended intervention for patients with intermittent claudication (IC). However, due to the limited availability of SEP, home-based structured exercise programs (HSEP) have become increasingly popular alongside the "go home and walk" advice. We evaluated the cost-effectiveness of walk advice (WA) with Nordic pole walking vs. SEP combined with WA or HSEP combined with WA. We used data from the SUNFIT RCT (NCT02341716) to measure quality-adjusted life-years (QALYs) over a 12-month follow-up, and economic costs were obtained from a hospital cost-per-patient accounting system. Incremental cost-effectiveness ratios (ICERs) were calculated, and uncertainty was assessed using nonparametric bootstrapping. The average health-care-cost per patient was similar in the WA (EUR 1781, n = 51) and HSEP (EUR 1820, n = 48) groups but higher in the SEP group (EUR 4619, n = 50, -value < 0.01). Mean QALYs per patient during the follow-up were similar with no statistically significant differences. The findings do not support SEP as a cost-effective treatment for IC, as it incurred significantly higher costs without providing additional health improvements over WA with or without HSEP during the one-year observation period. The analysis also suggested that HSEP may be cost-effective compared to WA, but only with a 64% probability.

References

Aboyans V, Ricco J, Bartelink M, Bjorck M, Brodmann M, Cohnert T . 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric,.... Eur Heart J. 2017; 39(9):763-816. DOI: 10.1093/eurheartj/ehx095. View

Gerhard-Herman M, Gornik H, Barrett C, Barshes N, Corriere M, Drachman D . 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016; 135(12):e726-e779. PMC: 5477786. DOI: 10.1161/CIR.0000000000000471. View

Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E . A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 2007; 45(6):1185-91. DOI: 10.1016/j.jvs.2007.02.004. View

van den Houten M, Lauret G, Fakhry F, Fokkenrood H, van Asselt A, Hunink M . Cost-effectiveness of supervised exercise therapy compared with endovascular revascularization for intermittent claudication. Br J Surg. 2016; 103(12):1616-1625. DOI: 10.1002/bjs.10247. View

Canonico M, Piccolo R, Avvedimento M, Leone A, Esposito S, Franzone A . Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions. J Cardiovasc Dev Dis. 2023; 10(4). PMC: 10144744. DOI: 10.3390/jcdd10040164. View

Manca A, Hawkins N, Sculpher M . Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility. Health Econ. 2004; 14(5):487-96. DOI: 10.1002/hec.944. View

Back M, Jivegard L, Johansson A, Nordanstig J, Svanberg T, Adania U . Home-based supervised exercise versus hospital-based supervised exercise or unsupervised walk advice as treatment for intermittent claudication: a systematic review. J Rehabil Med. 2015; 47(9):801-8. DOI: 10.2340/16501977-2012. View

Parmenter B, Dieberg G, Phipps G, Smart N . Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2014; 20(1):30-40. DOI: 10.1177/1358863X14559092. View

Makris G, Lattimer C, Lavida A, Geroulakos G . Availability of supervised exercise programs and the role of structured home-based exercise in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2012; 44(6):569-75. DOI: 10.1016/j.ejvs.2012.09.009. View

10.

Song P, Rudan D, Zhu Y, Fowkes F, Rahimi K, Fowkes F . Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health. 2019; 7(8):e1020-e1030. DOI: 10.1016/S2214-109X(19)30255-4. View

11.

Fakhry F, Fokkenrood H, Spronk S, Teijink J, Rouwet E, Hunink M . Endovascular revascularisation versus conservative management for intermittent claudication. Cochrane Database Syst Rev. 2018; 3:CD010512. PMC: 6494207. DOI: 10.1002/14651858.CD010512.pub2. View

12.

Bartelink M, Stoffers H, Biesheuvel C, Hoes A . Walking exercise in patients with intermittent claudication. Experience in routine clinical practice. Br J Gen Pract. 2004; 54(500):196-200. PMC: 1314830. View

13.

Djerf H, Falkenberg M, Jivegard L, Lindgren H, Svensson M, Nordanstig J . Cost-effectiveness of revascularization in patients with intermittent claudication. Br J Surg. 2018; 105(13):1742-1748. DOI: 10.1002/bjs.10992. View

14.

Milani R, Lavie C . The role of exercise training in peripheral arterial disease. Vasc Med. 2007; 12(4):351-8. DOI: 10.1177/1358863X07083177. View

15.

van Asselt A, Nicolai S, Joore M, Prins M, Teijink J . Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a 'go home and walk' advice. Eur J Vasc Endovasc Surg. 2010; 41(1):97-103. DOI: 10.1016/j.ejvs.2010.06.024. View

16.

Gardner A, Parker D, Montgomery P, Scott K, Blevins S . Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation. 2011; 123(5):491-8. PMC: 3154843. DOI: 10.1161/CIRCULATIONAHA.110.963066. View

17.

Nicolai S, Teijink J, Prins M . Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication. J Vasc Surg. 2010; 52(2):348-55. DOI: 10.1016/j.jvs.2010.02.022. View

18.

Murphy T, Cutlip D, Regensteiner J, Mohler 3rd E, Cohen D, Reynolds M . Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015; 65(10):999-1009. PMC: 5278564. DOI: 10.1016/j.jacc.2014.12.043. View

19.

Fowkes F, Rudan D, Rudan I, Aboyans V, Denenberg J, McDermott M . Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013; 382(9901):1329-40. DOI: 10.1016/S0140-6736(13)61249-0. View

20.

Sterne J, White I, Carlin J, Spratt M, Royston P, Kenward M . Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009; 338:b2393. PMC: 2714692. DOI: 10.1136/bmj.b2393. View